These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 29523103

  • 1. Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.
    Kim M, Song C, Jeong IG, Choi SK, Park M, Shim M, Kim YS, You D, Hong JH, Kim CS, Ahn H.
    BMC Cancer; 2018 Mar 09; 18(1):271. PubMed ID: 29523103
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
    Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A.
    Eur Urol; 2018 Apr 09; 73(4):512-518. PubMed ID: 29229176
    [Abstract] [Full Text] [Related]

  • 5. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
    Boehm K, Schiffmann J, Tian Z, Lesmana H, Larcher A, Mandel P, Karakiewicz PI, Graefen M, Schwarz R, Krüll A, Tilki D.
    Urol Oncol; 2016 Mar 09; 34(3):119.e11-8. PubMed ID: 26602027
    [Abstract] [Full Text] [Related]

  • 6. Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy.
    Yoo S, You D, Kim YS, Hong JH, Ahn H, Kim CS.
    Urol Int; 2017 Mar 09; 99(4):406-413. PubMed ID: 29020683
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy.
    Matsumoto K, Niwa N, Hagiwara M, Kosaka T, Takeda T, Yasumizu Y, Tanaka N, Morita S, Mizuno R, Shinojima T, Hara S, Asanuma H, Oya M.
    Int J Clin Oncol; 2021 Apr 09; 26(4):744-752. PubMed ID: 33387085
    [Abstract] [Full Text] [Related]

  • 8. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy.
    Ghadjar P, Aebersold DM, Albrecht C, Böhmer D, Flentje M, Ganswindt U, Höcht S, Hölscher T, Sedlmayer F, Wenz F, Zips D, Wiegel T, Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party Radiation Oncology of the German Cancer Society (DKG-ARO).
    Strahlenther Onkol; 2018 Jul 09; 194(7):619-626. PubMed ID: 29383406
    [Abstract] [Full Text] [Related]

  • 9. Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis.
    Park JW, Jang WS, Koh DH, Ham WS, Rha KH, Hong SJ, Choi YD.
    Yonsei Med J; 2018 Jul 09; 59(5):580-587. PubMed ID: 29869455
    [Abstract] [Full Text] [Related]

  • 10. Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer.
    Pak S, You D, Jeong IG, Kim YS, Hong JH, Kim CS, Ahn H.
    Int J Clin Oncol; 2019 Oct 09; 24(10):1238-1246. PubMed ID: 31087170
    [Abstract] [Full Text] [Related]

  • 11. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
    Jackson WC, Schipper MJ, Johnson SB, Foster C, Li D, Sandler HM, Palapattu GS, Hamstra DA, Feng FY.
    Eur Urol; 2016 Jan 09; 69(1):50-7. PubMed ID: 26004800
    [Abstract] [Full Text] [Related]

  • 12. Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer.
    Taguchi S, Fukuhara H, Azuma T, Suzuki M, Fujimura T, Nakagawa T, Ishikawa A, Kume H, Igawa Y, Homma Y.
    BMC Urol; 2014 Oct 16; 14():81. PubMed ID: 25323845
    [Abstract] [Full Text] [Related]

  • 13. Salvage radiation therapy following radical prostatectomy. A national Danish study.
    Ervandian M, Høyer M, Petersen SE, Sengeløv L, Hansen S, Holmberg M, Sveistrup J, Meidahl Petersen P, Borre M.
    Acta Oncol; 2016 May 16; 55(5):598-603. PubMed ID: 26399602
    [Abstract] [Full Text] [Related]

  • 14. Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution study.
    Tumati V, Jackson WC, Abugharib AE, Raj G, Roehrborn C, Lotan Y, Courtney K, Bagrodia A, Gahan JC, Zumsteg ZS, Folkert MR, Laine AM, Hannan R, Spratt DE, Desai NB.
    BJU Int; 2018 Mar 16; 121(3):365-372. PubMed ID: 28581200
    [Abstract] [Full Text] [Related]

  • 15. Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.
    Artibani W, Porcaro AB, De Marco V, Cerruto MA, Siracusano S.
    Urol Int; 2018 Mar 16; 100(3):251-262. PubMed ID: 29161715
    [Abstract] [Full Text] [Related]

  • 16. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
    Obata H, Shiota M, Akitake N, Takeuchi A, Kashiwagi E, Dejima T, Kiyoshima K, Inokuchi J, Tatsugami K, Eto M.
    Anticancer Res; 2017 Oct 16; 37(10):5631-5637. PubMed ID: 28982880
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcomes of salvage treatment in lymph node-positive prostate cancer patients after radical prostatectomy.
    Kim D, Kim DY, Kim JS, Hong SK, Byun SS, Lee SE.
    PLoS One; 2021 Oct 16; 16(9):e0256778. PubMed ID: 34506516
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study.
    Qin X, Han C, Zhang H, Dai B, Zhu Y, Shen Y, Zhu Y, Shi G, Ye D.
    World J Surg Oncol; 2015 May 06; 13():172. PubMed ID: 25943443
    [Abstract] [Full Text] [Related]

  • 19. Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.
    Yang DD, Muralidhar V, Mahal BA, Nezolosky MD, Labe SA, Vastola ME, Boldbaatar N, King MT, Martin NE, Orio PF, Choueiri TK, Trinh QD, Den RB, Spratt DE, Hoffman KE, Feng FY, Nguyen PL.
    Urol Oncol; 2017 Sep 06; 35(9):542.e25-542.e32. PubMed ID: 28533151
    [Abstract] [Full Text] [Related]

  • 20. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.
    Messing EM, Manola J, Yao J, Kiernan M, Crawford D, Wilding G, di'SantAgnese PA, Trump D, Eastern Cooperative Oncology Group study EST 3886.
    Lancet Oncol; 2006 Jun 06; 7(6):472-9. PubMed ID: 16750497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.